|
|
 |
|
Viewing report
|
|
 |
 |
Molecular Cancer Therapeutics: Strategies for Drug Discovery and Development
John Wiley and Sons Ltd, April 2004, Pages: 351
Molecular Cancer Therapeutics covers state-of-the-art strategies to identify and develop cancer drug target molecules and lead inhibitors for clinical testing. It provides a thorough treatment of drug target discovery, validation, and development. The introductory chapters provide an overview of pathways to discovery and development of molecular cancer therapeutics. Subsequent chapters progress from initial stages of drug target discovery to drug discovery, development, and testing in preclinical and clinical models. Topics include drug lead screening, drug-to-lead development, proof-of-concept studies, medicinal chemistry issues, intellectual property concerns, and clinical development. This invaluable reference promotes understanding of steps involved in developing drug leads for industrial partnering and development. It provides an overview of the strategies for discovery and validation of drug target molecules, and discusses cell- and molecule-based drug screening strategies, as well as mouse models for cancer. Coverage also includes how to refine drug leads for suitability in clinical testing, the special issues of clinical testing of molecular-targeted drugs, and intellectual property concerns.
Customers who bought this item also bought
Molecular Pathology in Drug Discovery and Development
Genomics in Drug Discovery and Development
Cancer Drug Resistance
Drug Delivery in Cancer - Technologies, Markets and Companies
Innovations in Bioinformatics: Emerging Tools for Drug Discovery and Development
Companion Biomarkers in Drug Development
Overview of the European Drug Discovery Market
Antiparasitic and Antibacterial Drug Discovery: From Molecular Targets to Drug Candidates
Pharmacogenomics for Clinical Use and in Drug Development
Molecular Biomarkers for Clinical Diagnostics and Drug Discovery and Development
Advances in Lab-on-Chip and Microfluidics Technologies for Drug Discovery and Clinical Diagnostics
Currently Druggable in Colorectal Cancer: A Drug Target Competitive Analysis
|
 |
|
|